Breast Cancer Markers

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090192107A1
SERIAL NO

12226012

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for the detection of the presence of or the risk of cancer in a patient, comprising, with reference to a normal control, the step of: (i) detecting the expression level of a gene characterised by any of the nucleotide sequences identified herein as SEQ ID No. 1 to SEQ ID No. 10, in a sample isolated from a patient, wherein an increased expression level of the gene characterised by any of SEQ ID Nos. 1 to 6 and 10, or a decreased expression level of the gene characterised by any of SEQ ID Nos. 7 to 9, indicates the presence of or the risk of cancer in the patient from whom the sample was isolated.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RANDOX LABORATORIES LTDARDMORE DIAMOND ROAD CRUMLIN CO ANTRIM BT29 4QU

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Crockard, Martin Andrew Co. Antrim , IE 4 5
Fitzgerald, Stephen Peter Co.antrim , IE 56 341
Lamont, John Victor Co.antrim , IE 27 272

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation